Skip to content

STREAMLINE HEALTH SOLUTIONS INC.: 10-Q filed 2014-12-09

What STREAMLINE HEALTH SOLUTIONS INC. reported in its quarterly report filed 2014-12-09 (fiscal Q3 2014): 37 published measures, 104 facts as tagged in accession 0001008586-14-000011.

This filing

Form
10-Q (quarterly report)
Filed
2014-12-09
Fiscal period
fiscal Q3 2014
Accession
0001008586-14-000011 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All STREAMLINE HEALTH SOLUTIONS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-10-3156,749,210USD
At 2014-01-3165,578,874USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-10-3127,024,653USD
At 2014-01-3130,488,159USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-10-3123,373,388USD
At 2014-01-3129,491,047USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-10-315,944,750USD
At 2014-01-3117,924,886USD
At 2013-10-314,263,991USD
At 2013-01-317,500,256USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-08-01 to 2014-10-31-2,255,564USD92
2014-02-01 to 2014-10-31-7,201,814USD273
2013-08-01 to 2013-10-31-6,232,418USD92
2013-02-01 to 2013-10-31-9,770,468USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-02-01 to 2014-10-31-2,361,980USD273
2013-02-01 to 2013-10-31762,281USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-02-01 to 2014-10-311,862,855USD273
2013-02-01 to 2013-10-31106,392USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-02-01 to 2014-10-31-1,193,612USD273
2013-02-01 to 2013-10-31155,784USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-02-01 to 2014-10-31-8,424,544USD273
2013-02-01 to 2013-10-31-4,154,330USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-10-31-54,764,527USD
At 2014-01-31-47,562,713USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-08-01 to 2014-10-3118,309,677shares92
2014-02-01 to 2014-10-3118,210,034shares273
2013-08-01 to 2013-10-3113,257,943shares92
2013-02-01 to 2013-10-3112,884,711shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-08-01 to 2014-10-3118,309,677shares92
2014-02-01 to 2014-10-3118,210,034shares273
2013-08-01 to 2013-10-3113,257,943shares92
2013-02-01 to 2013-10-3112,884,711shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-08-01 to 2014-10-31-0.14USD/shares92
2014-02-01 to 2014-10-31-0.44USD/shares273
2013-08-01 to 2013-10-31-0.5USD/shares92
2013-02-01 to 2013-10-31-0.82USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-08-01 to 2014-10-31-0.14USD/shares92
2014-02-01 to 2014-10-31-0.44USD/shares273
2013-08-01 to 2013-10-31-0.5USD/shares92
2013-02-01 to 2013-10-31-0.82USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-08-01 to 2014-10-310USD92
2014-02-01 to 2014-10-312,290USD273
2013-08-01 to 2013-10-31-4,680USD92
2013-02-01 to 2013-10-31158,944USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-10-313,278,841USD
At 2014-01-31919,044USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-08-01 to 2014-10-31421,000,000USD92
2014-02-01 to 2014-10-311,286,145USD273
2013-08-01 to 2013-10-31378,000,000USD92
2013-02-01 to 2013-10-311,203,919USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-08-01 to 2014-10-31-2,712,678USD92
2014-02-01 to 2014-10-31-8,364,912USD273
2013-08-01 to 2013-10-31-1,146,269USD92
2013-02-01 to 2013-10-31-1,559,894USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-10-3114,724,580USD
At 2014-01-3129,688,229USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-08-01 to 2014-10-31180,583USD92
2014-02-01 to 2014-10-31523,599USD273
2013-08-01 to 2013-10-31580,390USD92
2013-02-01 to 2013-10-311,734,763USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-10-3114,435,060USD
At 2014-01-3115,411,979USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-10-312,173,577USD
At 2014-01-311,796,418USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-10-3115,889,595USD
At 2014-01-3111,933,683USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-10-315,917,038USD
At 2014-01-317,999,571USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-08-01 to 2014-10-314,230,347USD92
2014-02-01 to 2014-10-3112,925,597USD273
2013-08-01 to 2013-10-313,373,230USD92
2013-02-01 to 2013-10-3110,362,246USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-08-01 to 2014-10-312,275,410USD92
2014-02-01 to 2014-10-316,850,973USD273
2013-08-01 to 2013-10-311,370,178USD92
2013-02-01 to 2013-10-313,627,336USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-10-3118,458,745shares
At 2014-01-3118,175,787shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-10-310USD
At 2014-01-31-111,086USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-10-319,291,277USD
At 2014-01-317,595,868USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-10-316,012,436USD
At 2014-01-316,676,824USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-10-3111,797,610USD
At 2014-01-3112,175,634USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-08-01 to 2014-10-31-2,145,195USD92
2014-02-01 to 2014-10-31-7,090,728USD273
2013-08-01 to 2013-10-31-6,232,418USD92
2013-02-01 to 2013-10-31-9,770,468USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-08-01 to 2014-10-31-2,524,716USD92
2014-02-01 to 2014-10-31-7,953,315USD273
2013-08-01 to 2013-10-31-6,606,580USD92
2013-02-01 to 2013-10-31-10,501,777USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-02-01 to 2014-10-31670,955USD273
2013-02-01 to 2013-10-31490,043USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-02-01 to 2014-10-311,051,025USD273
2013-02-01 to 2013-10-31946,228USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-08-01 to 2014-10-31752,219USD92
2014-02-01 to 2014-10-311,803,509USD273
2013-08-01 to 2013-10-31-4,510,439USD92
2013-02-01 to 2013-10-31-6,316,867USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-02-01 to 2014-10-31410,395USD273
2013-02-01 to 2013-10-3187,014USD273

Inspect the source

Entity
STREAMLINE HEALTH SOLUTIONS INC. / CIK 0001008586
Captured
2026-09-21T17:17:56.440Z
SEC response SHA-256
f28ec2b62f459f9e1502e7518fb1b41cf9eab0c85e2282d838d54aa5e44579c9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001008586.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))